Vaginal Fetal Fibronectin Levels and Spontaneous Preterm Birth in Symptomatic Women

@article{Lu2001VaginalFF,
  title={Vaginal Fetal Fibronectin Levels and Spontaneous Preterm Birth in Symptomatic Women},
  author={G. Lu and R. Goldenberg and S. Cliver and U. Kreaden and W. Andrews},
  journal={Obstetrics \& Gynecology},
  year={2001},
  volume={97},
  pages={225–228}
}
Objective To relate vaginal fetal fibronectin levels in women with symptoms of preterm labor to subsequent spontaneous preterm birth. Methods Quantitative fetal fibronectin values were calculated from women who participated in two prospective multicenter trials relating fetal fibronectin to subsequent spontaneous preterm birth. The study populations consisted of women who presented with symptoms of preterm labor between 240/7 and 346/7 weeks, a singleton pregnancy, intact membranes, no prior… Expand
Interleukins & Fetal Fibronectin Levels In Preterm Delivery
TLDR
C cervicovaginal measurement of fetal fibronectin, IL-lB and IL-8 in combination with clinical findings may be useful for the evaluation of patients with threatened premature delivery. Expand
Fetal Fibronectin and Adverse Infant Outcomes in a Predominantly Human Immunodeficiency Virus–Infected African Population: A Randomized Controlled Trial
TLDR
In a population of predominantly HIV- infected African women, fetal fibronectin concentrations at 28 but not at 20–24 weeks were associated with increased risk of preterm birth, and the associations were stronger for early pre term birth and when fetal fibronsectin levels were higher. Expand
Interleukin 6 and fetal fibronectin as a predictors of preterm delivery in symptomatic patients.
TLDR
The combination of both tests performed better than the individual tests and decreased the false positive rate, which in turn reduced the chances for inappropriate patient treatment, bringing down the costs. Expand
The value of fetal fibronectin in cervicovaginal secretions and standard markers of infection in predicting preterm delivery for patients with symptoms and intact membranes
TLDR
The detection of fetal fibronectin in cervicovaginal secretions allows identification of patients at high risk of preterm delivery, and high level of C-reactive protein and white blood cells count appear to correlate with increased rate of prematurity. Expand
What we have learned from an antibiotic trial in fetal fibronectin positive women.
TLDR
No significant difference was observed between the antibiotic- and placebo-treated groups for spontaneous preterm delivery before 37 week's gestation, and use of the fetal fibronectin test to identify women for antibiotic treatment in an effort to prevent preterm birth should be discouraged. Expand
Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
TLDR
In asymptomatic women with a prior PTD, quantitative fFN assessment at 24 weeks effectively delineates the risk of recurrent sPTD. Expand
Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women.
OBJECTIVE The purpose of this study was to determine whether quantification of cervicovaginal fluid fetal fibronectin (fFN) improves diagnostic accuracy of spontaneous preterm birth (sPTB) inExpand
Predictive value of the quantitative fetal fibronectin levels for the management of women presenting with threatened preterm labour – A revised cut off level: A retrospective cohort study
TLDR
In women presenting with TPL, those with levels of <200 ng ml−1 have a low risk of birthing within 7 d or before 34 weeks gestation, which allows a personalised decision making and probable discharge home without need for steroid loading. Expand
Comparison of maternal and neonatal outcome before and after the availability of a rapid assay for fetal fibronectin at a tertiary level maternity hospital
TLDR
Findings suggest that implementation of FFN testing in clinical settings takes time and requires more rigorous policies for use to replicate previous research findings, and that predictive algorithms using the best evidence and predictive factors for subpopulations may lead to improved diagnostic precision in the future. Expand
Examining the relationship between positive mid-gestational fetal fibronectin assays and histological evidence of acute placental inflammation
TLDR
No association exists between positive fetal fibronectin assays and acute histologic placental inflammation at birth and women with positive assays were no more likely to have histological evidence of acute inflammation noted at birth. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 12 REFERENCES
Fetal fibronectin in patients at increased risk for premature birth.
TLDR
Fetal fibronectin in the cervicovaginal secretions of asymptomatic patients has potential value as a screening test in the identification of patients at risk for preterm birth. Expand
Fetal fibronectin improves the accuracy of diagnosis of preterm labor.
TLDR
Cervicovaginal fetal fibronectin predicts delivery within 7 days more accurately than do cervical dilatation and contraction frequency in a population of women evaluated for early preterm labor. Expand
Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial.
TLDR
In a population of patients with symptoms, the presence of fetal fibronectin in vaginal secretions best defines a subgroup at increased risk for delivery within 7 days; the high negative predictive value of fetal fibre sampling supports less intervention for patients with this result. Expand
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery.
TLDR
The presence of cervicovaginal fetal fibronectin in the second and third trimesters of pregnancy identifies a subgroup of women who are at high risk for preterm delivery. Expand
The Preterm Prediction Study: Fetal Fibronectin Testing and Spontaneous Preterm Birth
TLDR
Although fetal fibronectin is an excellent test for predicting spontaneous preterm birth, it is presented no evidence that the use of this test will result in a reduction in spontaneous pre term birth. Expand
The Preterm Prediction Study: Fetal Fibronectin, Bacterial Vaginosis, and Peripartum Infection
TLDR
A positive cervical fetal fibronectin test was a better predictor of clinical chorioamnionitis and neonatal sepsis than was a vaginal test or a combination of vaginal and cervical tests. Expand
The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
TLDR
The presence of a positive cervical or vaginal fetal fibronectin test result predicts subsequent positive fetal fibronsectin positivity and subsequent spontaneous preterm birth. Expand
The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
TLDR
Increasing levels of cervicovaginal fetal fibronectin up to 300 ng/mL are associated with an increasing risk of spontaneous preterm birth, and at 24 to 30 weeks, the value currently used appears to be a reasonable cutoff point for predicting spontaneous pre term birth at <35 weeks' gestation. Expand
Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery.
TLDR
The combination of preterm birth-risk score and vaginal fetal fibronectin FDC-6 predicted spontaneous pre Term birth, and intervention trials are required to determine whether a combination of screening tests will reduce rates of spontaneous pre term birth. Expand
PREDICTION OF PRETERM DELIVERY BY FETAL FIBRONECTIN: A META‐ANALYSIS
TLDR
Fetal fibronectin in cervicovaginal secretions is associated with preterm delivery in both high-risk and low-risk women. Expand
...
1
2
...